Recent Updates
Recently added Catalysts
ORIC Positive Sentiment

ORIC Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Monday, January 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ORIC Pharmaceuticals, a clinical stage oncology company, announced that CEO Jacob M. Chacko will present an overview of the company at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. This presentation is an opportunity for ORIC to showcase its developments in combating therapeutic resistance in oncology. A live webcast of the presentation will be accessible on the company's website, with a replay available for up to 90 days post-event. The participation in such a significant conference indicates the company’s proactive outreach to investors and stakeholders.
Price reaction · baseline $8.55 (2025-01-03 close) · clean, no other ORIC news in the window
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is gaining visibility by presenting at a prestigious conference.
  • The presentation could potentially attract investor interest and funding.
  • The company focuses on addressing therapeutic resistance in oncology, an important and relevant field.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+58%
120-day peak, hindsight
Typical move
10.1%
average across 6 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
ORIC-944
Phase 1 · Metastatic Prostate Cancer

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 11:15 a.m. PT.
A live webcast of the company presentation will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.

Frequently Asked Questions

When will ORIC Pharmaceuticals present at the J.P. Morgan Conference?

ORIC Pharmaceuticals will present on January 14, 2025, at 11:15 a.m. PT.

How can I watch the ORIC Pharmaceuticals presentation?

The presentation can be viewed live via the investor section on ORIC's website.

Is there a replay available for the ORIC conference presentation?

Yes, a replay of the presentation will be accessible for 90 days after the event.

Who is the CEO of ORIC Pharmaceuticals?

Jacob M. Chacko, M.D., is the CEO of ORIC Pharmaceuticals.

How can I contact the CFO of ORIC Pharmaceuticals?

Dominic Piscitelli can be contacted at dominic.piscitelli@oricpharma.com.

ShareAdd on Google
Tags: ORIC Viatris Investor Conferences Healthcare J.P. Morgan oncology therapeutic resistance biopharma
Last updated: Jan 6, 2025

Biotech snapshot

Cash runway
$388M liquidity · $11M/mo burn
~36 mo
Minimal dilution risk
Lead asset
ORIC-944Phase 1
Metastatic Prostate Cancer →

Catalyst track record

+58%
best trade around ORIC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for ORIC.

See every catalyst's timing & PoA →